Send me a link:

*Text messaging rates may apply.

 Dow Down 0.41% Nasdaq Down 0.52%

Portola Pharmaceuticals, Inc. (PTLA)

-NMS
25.62 Down 0.57(2.18%) 4:00PM EDT
- Nasdaq Real Time Price
Prev Close:26.19
Open:25.26
Bid:25.67 x 200
Ask:25.71 x 300
1y Target Est:38.50
Beta:-2.723
Earnings Date:Aug 11 - Aug 15 (Est.)
Day's Range:25.14 - 26.12
52wk Range:19.59 - 31.48
Volume:206,995
Avg Vol (3m):358,348
Market Cap:1.05B
P/E (ttm):N/A
EPS (ttm):-2.93
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PTLA

Comparison

Symbol% ChgMkt Cap
PTLADown 2.18%1.05B
BAYRYDown 2.37%113.91B
PFEDown 0.17%191.36B
SNYDown 1.23%136.30B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):109.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.44
Quarterly EPS Est (Jun-14) :-0.79
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops product candidates in the fields of thrombosis and hematology. Its lead compound, Betrixaban, is an oral, once-daily Factor Xa inhibitor in Phase III study for hospital to home p... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback